Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.
about
Active Tumor Permeation and Uptake of Surface Charge-Switchable Theranostic Nanoparticles for Imaging-Guided Photothermal/Chemo Combinatorial Therapy.Cell or cell membrane-based drug delivery systemsSynthetic Nanoparticles for Vaccines and ImmunotherapyTumor ablation and nanotechnology.Irradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for Cancer Therapy.Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cellsCarbon nanotubes enhance CpG uptake and potentiate antiglioma immunity.RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma.Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma.Irradiation promotes an m2 macrophage phenotype in tumor hypoxia.Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice.Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.The controversial role of microglia in malignant gliomas.Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.Bio-inspired, bioengineered and biomimetic drug delivery carriers.Cyclodextrin-containing polymers: versatile platforms of drug delivery materials.Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications.Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies.Multifunctional nanoparticles for targeting cancer and inflammatory diseases.Supramolecular cyclodextrin-based drug nanocarriers.Tumor-associated macrophages and anti-tumor therapies: complex links.Cancer nanomedicine: progress, challenges and opportunities.The immunological function of GABAergic system.Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.Nanomedicine Strategies to Target Tumor-Associated Macrophages.Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.Cell damage produced by magnetic fluid hyperthermia on microglial BV2 cellsParticle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors.
P2860
Q27300862-017EF3A0-FA80-4B92-89CC-6BD0171FD060Q28080710-A21A4D03-424C-484F-B4D5-71A519325AD4Q28085375-213C9AE3-CA92-4438-BF61-41EE11DB9219Q28385067-CEEE0D63-0C3F-4C01-89B4-A05B5D707322Q30401659-6D61C2D0-FEB8-4C9D-8537-D1BE9B33CC78Q34331704-D3170FD3-2052-4CAD-A28C-C86DACCE5D63Q34586673-E65F1F21-2185-4F36-B083-0CD347E05A4CQ34716082-B2546975-E2C2-42A3-A48D-5B1A838290D0Q35845261-E1E89208-CD99-4300-8061-22B48662C268Q36142366-37FE46AA-B5A4-48F6-8FBE-B452CDF231E5Q36353528-B5F5D819-B44E-49BB-A8B1-52A62CC773E3Q36454892-60714100-6E89-4513-898C-EAA624616DE6Q37091110-1D8660A3-1D7C-4F49-85B8-0A82BFCF5A0CQ37476252-17947F22-3A7F-4885-AB5E-701F58183D33Q37896455-002DC76E-CF59-44C0-A8C2-8DD1C854DB2CQ38002033-2C116C39-D35A-474C-B06B-941FCE6CE714Q38109107-7A5B601E-9715-4030-BBCA-F95900F75A72Q38122365-5B898875-55CC-4681-A143-1A814FF59635Q38136253-96D0A0AA-87EF-4950-9CB9-791FB7D8E6E8Q38354545-CD304A2C-7C0F-4050-BB8A-7D8DC491C8CCQ38766176-3AAD6FC0-619E-4D50-A629-2BCE10130E9DQ39005226-4405B6AE-7205-4C57-81A4-A7A3C0F5E099Q39242855-D0BFBCEC-9317-4121-99B3-7D5343404788Q39280710-B655A1AA-C6F1-4E67-B097-EE7318F6AF00Q39283111-7E7ECD77-1BD1-4106-B156-FF3599C2AD88Q39458957-DE460D8D-E74B-463D-A610-D17FB03A4464Q41446969-CCC78DD2-1664-44E5-809D-62AD384A19CBQ49628457-5F7FBCFC-CFE4-4ACE-B6D2-BA06A0B06B8A
P2860
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Tumor-associated macrophages a ...... ed nanoparticles into gliomas.
@ast
Tumor-associated macrophages a ...... ed nanoparticles into gliomas.
@en
type
label
Tumor-associated macrophages a ...... ed nanoparticles into gliomas.
@ast
Tumor-associated macrophages a ...... ed nanoparticles into gliomas.
@en
prefLabel
Tumor-associated macrophages a ...... ed nanoparticles into gliomas.
@ast
Tumor-associated macrophages a ...... ed nanoparticles into gliomas.
@en
P2093
P2860
P1476
Tumor-associated macrophages a ...... ed nanoparticles into gliomas.
@en
P2093
Behnam Badie
Darya Alizadeh
Jungyeon Hwang
Leying Zhang
Thomas Schluep
P2860
P304
P356
10.1016/J.NANO.2009.10.001
P577
2009-11-05T00:00:00Z